In a new study by researchers at Yale Cancer Center, combining the immunotherapy drug durvalumab and PARP-inhibitor olaparib with chemotherapy improved response to treatment for women with high-risk, HER2-negative breast cancer, including a subset of estrogen receptor positive cancers. The…
Read More
Endocrine Society praises U.S. Supreme Court's decision to uphold the ACA
The Endocrine Society today praised the U.S. Supreme Court's decision to uphold the Affordable Care Act, which makes health care accessible to millions of individuals nationwide, including those with hormone health conditions such as diabetes, osteoporosis, thyroid conditions, and breast…
Read More
MicroRNAs in urine could be a promising biomarker to diagnose brain tumors, study reveals
A recent study by Nagoya University researchers revealed that microRNAs in urine could be a promising biomarker to diagnose brain tumors. Their findings, published in the journal ACS Applied Materials & Interfaces, have indicated that regular urine tests could help…
Read More
Study: Genetic mutations associated with breast cancer risk are the same in Black and white women
The prevalence of genetic mutations associated with breast cancer in Black and white women is the same, according to a new JAMA Oncology study of nearly 30,000 patients led by researchers in the Basser Center for BRCA at the Abramson…
Read More
New bacterium shows promise for treating type 2 diabetes, obesity
It all started, when Patrice Cani, FNRS researcher at University of Louvain (UCLouvain), and his team repeatedly observed that a bacterium (called Subdoligranulum) is almost absent in obese and diabetic people, while it is systematically present in healthy people. So,…
Read More
TSMC grant could boost TGen's efforts to track SARS-CoV-2 variants
The Translational Genomics Research Institute (TGen), an affiliate of City of Hope, today announced a substantial grant from Taiwan Semiconductor Manufacturing Co. Ltd. (TSMC), one of the world's largest manufacturers of computer chips, to help TGen sustain Arizona's fight against…
Read More
Antibody treatment reactivates the immune defense in patients with advanced-stage cancer
Researchers at the University of Turku, Finland, showed that the antibody treatment reactivates the immune defense in patients with advanced-stage cancer. The treatment alters the function of the body's phagocytes and facilitates extensive activation of the immune system. The immune…
Read More
Study reveals prevalence of multimorbidity among people using methamphetamine
People who use methamphetamine are more likely to have health conditions, mental illness, and substance use disorders than people who do not use the drug, according to a new study by researchers at the Center for Drug Use and HIV/HCV…
Read More
Care worker given months to live thanks boss for spotting signs of tumour
Single mum and care worker Nicky Sale, 57, says her boss is a real life-saver. That’s no exaggeration. It was Nicky’s boss, Sheena Adams, 37, who spotted that something was seriously wrong and pushed Nicky to go to the doctors….
Read More
Cancer symptoms: The ‘most common’ physical mark of a growing melanoma – a deadly tumour
Skin cancer: Dr Chris outlines the signs of a melanoma When you subscribe we will use the information you provide to send you these newsletters. Sometimes they’ll include recommendations for other related newsletters or services we offer. Our Privacy Notice…
Read More